Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1975 1
1976 1
1981 2
1984 1
1986 1
1988 1
1991 1
1996 1
1997 1
1998 1
1999 1
2001 2
2002 2
2003 2
2005 1
2007 1
2008 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Screening and diagnosis of coagulation disorders.
Lusher JM. Lusher JM. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 2):778-83. doi: 10.1016/s0002-9378(96)80084-6. Am J Obstet Gynecol. 1996. PMID: 8828561 Review.
If von Willebrand disease is suspected (because of menorrhagia with or without other mucous membrane bleeding, a positive family history, and a prolonged activated partial thromboplastin time), more specific laboratory tests for this disease should be done. . …
If von Willebrand disease is suspected (because of menorrhagia with or without other mucous membrane bleeding, a positive family hist …
Treatment of von Willebrand's disease.
Mannucci PM. Mannucci PM. J Intern Med Suppl. 1997;740:129-32. J Intern Med Suppl. 1997. PMID: 9350194 Review.
The aim of therapy is to correct the dual defects of haemostasis, i.e. abnormal coagulation expressed by low levels of factor VIII and abnormal platelet adhesion expressed by a prolonged bleeding time. ...Treated with virucidal methods, these concentra …
The aim of therapy is to correct the dual defects of haemostasis, i.e. abnormal coagulation expressed by low levels of factor VIII an …
Disorders of platelet function: mechanisms, diagnosis and management.
Huebsch LB, Harker LA. Huebsch LB, et al. West J Med. 1981 Feb;134(2):109-27. West J Med. 1981. PMID: 7013276 Free PMC article. Review.
Platelets play an important role in hemostasis, and alterations in platelet function may be the cause of abnormal bleeding in a wide variety of congenital and acquired clinical disorders. ...A disorder of platelet function is suspected on the basis of the history and physi …
Platelets play an important role in hemostasis, and alterations in platelet function may be the cause of abnormal bleeding in a wide …
Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z. Michiels JJ, et al. Best Pract Res Clin Haematol. 2001 Jun;14(2):401-36. doi: 10.1053/beha.2001.0141. Best Pract Res Clin Haematol. 2001. PMID: 11686107 Review.
The laboratory findings of AVWS associated with systemic lupus erythematosus or IgG benign monoclonal gammopathy are characterized by a prolonged bleeding time and activated partial thromboplastin time, decreased or absent ristocetin-induced platelet a …
The laboratory findings of AVWS associated with systemic lupus erythematosus or IgG benign monoclonal gammopathy are characterized by a p …
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Michiels JJ, et al. Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230. Semin Thromb Hemost. 2005. PMID: 16276467 Review.
Recessive type 3 von Willebrand disease (vWD) is a severe hemophilia-like bleeding disorder caused by homozygosity or double heterozygosity for two nonsense mutations (null alleles) and characterized by a strongly prolonged bleeding time (BT), absence …
Recessive type 3 von Willebrand disease (vWD) is a severe hemophilia-like bleeding disorder caused by homozygosity or double heterozy …
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Federici AB, Castaman G, Mannucci PM; Italian Association of Hemophilia Centers (AICE). Federici AB, et al. Haemophilia. 2002 Sep;8(5):607-21. doi: 10.1046/j.1365-2516.2002.00672.x. Haemophilia. 2002. PMID: 12199668
von Willebrand disease (vWD) is a bleeding disorder caused by quantitative (type 1 and 3) or qualitative (type 2) defects of von Willebrand factor (vWF). ...Desmopressin is the treatment of choice in patients with type 1 vWD, who account for approximately 70% of cases, bec …
von Willebrand disease (vWD) is a bleeding disorder caused by quantitative (type 1 and 3) or qualitative (type 2) defects of von Will …
Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Castaman G, et al. Haematologica. 2003 Jan;88(1):94-108. Haematologica. 2003. PMID: 12551832 Free article. Review.
VWD has a prevalence of about 1% in the general population, but the figure for clinically relevant cases is lower (about 100/million inhabitants). Bleeding manifestations are heterogeneous: mucosal bleeding is typical of all VWD cases but hemarthrosis and hematomas …
VWD has a prevalence of about 1% in the general population, but the figure for clinically relevant cases is lower (about 100/million inhabit …
Treatment of von Willebrand disease.
Mannucci PM. Mannucci PM. Haemophilia. 1998 Jul;4(4):661-4. doi: 10.1046/j.1365-2516.1998.440661.x. Haemophilia. 1998. PMID: 9873811 Review.
The aim of treatment is to correct the dual defects of haemostasis, i.e., abnormal coagulation expressed by low levels of factor VIII and abnormal platelet adhesion expressed by a prolonged bleeding time. There are two main options available for the managemen …
The aim of treatment is to correct the dual defects of haemostasis, i.e., abnormal coagulation expressed by low levels of factor VIII and ab …
Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
Mannucci PM. Mannucci PM. Blood. 1988 Nov;72(5):1449-55. Blood. 1988. PMID: 3052622 Free article. Review.
Because it can raise circulating levels of factor VIII coagulant activity (FVIII) and von Willebrand factor and shorten the prolonged bleeding time, DDAVP is established as a nontransfusional form of treatment for mild and moderate hemophilia and von Willebra …
Because it can raise circulating levels of factor VIII coagulant activity (FVIII) and von Willebrand factor and shorten the prolonged …
Advances in the genetics and treatment of von Willebrand disease.
Federici AB, Mannucci PM. Federici AB, et al. Curr Opin Pediatr. 2002 Feb;14(1):23-33. doi: 10.1097/00008480-200202000-00005. Curr Opin Pediatr. 2002. PMID: 11880730 Review.
von Willebrand disease (VWD) is a bleeding disorder caused by quantitative (type 1 and 3) or qualitative (type 2) defects of von Willebrand factor (VWF). ...The aim of treatment is to correct the dual defects of hemostasis, ie, abnormal coagulation expressed by low levels …
von Willebrand disease (VWD) is a bleeding disorder caused by quantitative (type 1 and 3) or qualitative (type 2) defects of von Will …
21 results